Home Therapeutic Areas Rare Diseases
Home Therapeutic Areas Rare Diseases
Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety.
PAH
About Redunix®
Redunix® Indication: Treatment of idiopathic or heritable pulmonary arterial hypertension (PAH) in patients with moderate symptoms. Strengths: 2.5 mg/ml, 5 mg/ml Dosage Form: Solution for Infusion Active Ingredient: Treprostinil Sodium
PAH
About Maacy®
Maacy® Indication: Treatment of pulmonary arterial hypertension (PAH) in adults. Strength: 10 mg Dosage Form: Film-Coated Tablets Active Ingredient: Macitentan
